Article
From genomic landscapes to personalized cancer management—is there a roadmap?
1 Oct 2010
Abstract excerpt
Despite rapid progress in annotating the human genome, progress in biomarker discovery has been limited, in part, due to the restricted adoption of biomarker analysis in clinical trials. In this short review we present a roadmap to drive progress in the field of personalized cancer management and patient stratification. We suggest that improved understanding of disease biology and drug response in advance of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
